A small molecular edit with a wide horizon
A new tRNA platform aims to turn one kind of genetic stop signal into a route toward many treatments.
Researchers at U of T, UHN and SickKids engineered transfer RNA to help cells read through premature stop signals and finish making proteins that would otherwise be cut short.
The work is still preclinical. Its promise lies in the shared mechanism: one engineered approach could eventually be adapted across diseases that carry the same kind of stop signal.
Sources 1
Chapter 03 · Science & TechnologyRead it in the issue →
